Alcohol deterrents

Largest ever trial of ketamine to treat alcohol abuse to launch across eight NHS sites

The phase III clinical trial will explore the use of low-dose ketamine combined with psychological support as a therapy for people with alcohol use disorder.…

People with substance use disorders need more compassion from community pharmacy

Several factors impact how services are delivered across integrated care boards that offer NHS Inclusion drug treatment services, making it increasingly difficult for people with substance use disorders to access the care they need when and where they need it.…

Searching for new medicines to treat alcohol addiction

Only a few drugs are licensed to treat alcoholism and, although reasonably effective, they are not suitable for everyone. Increased understanding of the underlying neuroscience of alcohol addiction is revealing a wealth of new possible drug targets, and a number of trials are under way.…

Researchers question evidence base for alcohol addiction drug

A drug used to treat problems associated with alcohol dependence in the UK was licensed and recommended for use on the NHS despite insufficient evidence to prove its effectiveness, according to researchers at the University of Stirling.…

Researchers question value of nalmefene for treating alcohol dependency

The value of nalmefene for reducing alcohol consumption in patients who are alcohol-dependent has been questioned by the authors of a systematic review and meta-analysis published in PLoS Medicine on 22 December 2015.…